Although subunit-based vaccines might
induce less immunogenicity than the other vaccine types, their efficacy can be significantly improved by rational design based on the
structural analysis of RBD of MERS-CoV S protein and by identification of the most stable and critical neutralizing fragment of RBD,
while eliminating non-neutralizing epitopes through immunofocusing (Ma et al., 2014b)